MYGN Competitors & Alternatives
Compare Myriad Genetics Inc with similar stocks in the same industry
Diagnostics & Research
MYGN
Main Stock$6.04
Tradestie Score
59
Market Cap
$719.23M
Revenue Growth
-0.2%
Analyst Upside
+3.5%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$73.12
|
$2.24B | - | 60 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.43
|
$2.22B | - | 61 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$92.53
|
$1.77B | - | 53 | Compare |
|
NEOG
Neogen Corp
|
$9.67
|
$1.26B | - | 62 | Compare |
|
OPK
Opko Health Inc.
|
$1.22
|
$1.23B | - | 57 | Compare |
|
NEO
NeoGenomics, Inc.
|
$14.23
|
$1.13B | - | 58 | Compare |
|
CDNA
CareDx, Inc.
|
$28.93
|
$798.40M | - | 61 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.46
|
$719.31M | - | 58 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$23.12
|
$667.77M | - | 59 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.03
|
$612.76M | - | 57 | Compare |
More MYGN Analysis
Data updated: Jul 15, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry